However, the approach remains fragmented without the targeting of major immune signals and mediators (i.e., TLR4 signaling, monocyte-derived macrophages activation) that could interact with the mechanism triggered by the pathology of AD. This evidence concerns the gene TLR4 and Alzheimer disease.